The Experts
In this Points of View, Healio poised the same questions to experts in three different specialties. Each specialist treats patients who by way of disease or treatment are immunocompromised in this time of the COVID-19 pandemic. Here, they each discuss how they position COVID-19 vaccinations when managing these immunocompromised patients.
Meet the experts:
Cassandra Calabrese, DO,assistant professor of medicine in the department of rheumatic and immunologic disease, and the department of infectious disease at Cleveland Clinic
Niraj Patel, MD, chair of the American College of Allergy, Asthma & Immunology COVID-19 Vaccine Task Force and chief of the division of infectious disease and immunology at Atrium Health Levine Children’s Hospital in Charlotte, North Carolina.
Robert J. Soiffer, MD, chair of the executive committee for clinical programs, vice chair of the department of medical oncology, and chief of the division of hematologic malignancies with Dana-Farber Cancer Institute, and Worthington and Margaret Collette professor of medicine in the field of hematologic oncology at Harvard Medical School.
Click Here to Manage Email Alerts